72 results
8-K/A
GRNA
GreenLight Biosciences Inc
13 Jul 23
Entry into a Material Definitive Agreement
5:09pm
://investors.greenlightbio.com/financial-information/sec-filings or by contacting the Company’s Investor Relations Department at press@greenlightbio.com … / or by contacting Parent’s Investor Relations Department at info@fall-line-cap.com or 650-235-4032.
In addition to the Offer to purchase, the related Letter
SC 14D9/A
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation (amended)
4:05pm
of the U.S. Department of Justice (the “Antitrust Division”), certain acquisition transactions may not be consummated unless certain information has … by the SEC at www.sec.gov or from GreenLight by contacting our Investor Relations department at (339) 204-5434 or investors@greenlightbio.com, or by going
SC 14D9
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
of the U.S. Department of Justice (the “Antitrust Division”), certain acquisition transactions may not be consummated unless certain information has been … at www.sec.gov or from GreenLight by contacting our Investor Relations department at (339) 204-5434 or investors@greenlightbio.com, or by going
SC TO-T
EX-99
SW MergerCo, Inc.
21 Jun 23
Third party tender offer statement
9:23am
Division of the U.S. Department of Justice (the “Antitrust Division”), certain acquisition transactions may not be consummated unless certain information … Street Plaza- 30th Floor
New York, NY 10004
Facsimile: (212) 616-7616
Attention: Compliance Department
Continental Stock Transfer & Trust Company
1
SC TO-T
EX-99
SW MergerCo, Inc.
21 Jun 23
Third party tender offer statement
9:23am
State Street Plaza- 30th Floor
New York, NY 10004
Facsimile: (212) 616-7616
Attention: Compliance Department
Continental Stock Transfer & Trust … Company
1 State Street Plaza- 30th Floor
New York, NY 10004
Facsimile: (212) 616-7616
Attention: Compliance Department
If delivering by E-Mail
SC TO-T
EX-99
d1i5g3n
21 Jun 23
Third party tender offer statement
9:23am
SC14D9C
r00yfahm6ll0nz9le
30 May 23
Written communication relating to third party tender offer
7:13am
8-K
EX-99.1
hchfkm
30 May 23
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
7:11am
8-K
fmkucrf2d9a qso0
30 May 23
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
7:11am
8-K
EX-2.1
qyfl9g x7loheg5
30 May 23
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
7:11am
424B3
694tqxu8012m0
6 Oct 22
Prospectus supplement
5:15pm
8-K
EX-99.1
3ja038br 74lt
15 Aug 22
GreenLight Biosciences Announces Second Quarter 2022 Financial
6:07pm
8-K
3ueeg f4hzw
29 Jul 22
NIH, GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants
5:26pm
424B3
bpquw
7 Apr 22
Prospectus supplement
4:02pm
POS AM
a605q em1k82m8toxa1
5 Apr 22
Prospectus update (post-effective amendment)
5:18pm